_version_ 1783598930753224704
author Bax, Heather J.
Khiabany, Atousa
Stavraka, Chara
Pellizzari, Giulia
Chan Wah Hak, Charleen
Robinson, Alexandra
Ilieva, Kristina M.
Woodman, Natalie
Naceur‐Lombardelli, Cristina
Gillett, Cheryl
Pinder, Sarah
Gould, Hannah J.
Corrigan, Christopher J.
Till, Stephen J.
Katugampola, Sidath
Barton, Claire
Winship, Anna
Ghosh, Sharmistha
Montes, Ana
Josephs, Debra H.
Spicer, James F.
Karagiannis, Sophia N.
author_facet Bax, Heather J.
Khiabany, Atousa
Stavraka, Chara
Pellizzari, Giulia
Chan Wah Hak, Charleen
Robinson, Alexandra
Ilieva, Kristina M.
Woodman, Natalie
Naceur‐Lombardelli, Cristina
Gillett, Cheryl
Pinder, Sarah
Gould, Hannah J.
Corrigan, Christopher J.
Till, Stephen J.
Katugampola, Sidath
Barton, Claire
Winship, Anna
Ghosh, Sharmistha
Montes, Ana
Josephs, Debra H.
Spicer, James F.
Karagiannis, Sophia N.
author_sort Bax, Heather J.
collection PubMed
description
format Online
Article
Text
id pubmed-7581190
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75811902020-10-29 Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate Bax, Heather J. Khiabany, Atousa Stavraka, Chara Pellizzari, Giulia Chan Wah Hak, Charleen Robinson, Alexandra Ilieva, Kristina M. Woodman, Natalie Naceur‐Lombardelli, Cristina Gillett, Cheryl Pinder, Sarah Gould, Hannah J. Corrigan, Christopher J. Till, Stephen J. Katugampola, Sidath Barton, Claire Winship, Anna Ghosh, Sharmistha Montes, Ana Josephs, Debra H. Spicer, James F. Karagiannis, Sophia N. Allergy Letters to the Editor John Wiley and Sons Inc. 2020-03-10 2020-08 /pmc/articles/PMC7581190/ /pubmed/32086828 http://dx.doi.org/10.1111/all.14245 Text en © 2020 The Authors. Allergy published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Bax, Heather J.
Khiabany, Atousa
Stavraka, Chara
Pellizzari, Giulia
Chan Wah Hak, Charleen
Robinson, Alexandra
Ilieva, Kristina M.
Woodman, Natalie
Naceur‐Lombardelli, Cristina
Gillett, Cheryl
Pinder, Sarah
Gould, Hannah J.
Corrigan, Christopher J.
Till, Stephen J.
Katugampola, Sidath
Barton, Claire
Winship, Anna
Ghosh, Sharmistha
Montes, Ana
Josephs, Debra H.
Spicer, James F.
Karagiannis, Sophia N.
Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate
title Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate
title_full Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate
title_fullStr Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate
title_full_unstemmed Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate
title_short Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate
title_sort basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor ige therapeutic candidate
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581190/
https://www.ncbi.nlm.nih.gov/pubmed/32086828
http://dx.doi.org/10.1111/all.14245
work_keys_str_mv AT baxheatherj basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT khiabanyatousa basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT stavrakachara basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT pellizzarigiulia basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT chanwahhakcharleen basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT robinsonalexandra basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT ilievakristinam basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT woodmannatalie basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT naceurlombardellicristina basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT gillettcheryl basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT pindersarah basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT gouldhannahj basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT corriganchristopherj basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT tillstephenj basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT katugampolasidath basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT bartonclaire basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT winshipanna basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT ghoshsharmistha basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT montesana basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT josephsdebrah basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT spicerjamesf basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate
AT karagiannissophian basophilactivationtestincancerpatientbloodevaluatingpotentialhypersensitivitytoanantitumorigetherapeuticcandidate